Stock listing
ASND Stock Price, News, Filings & Events — Ascendis Pharma A/s
Selected listing: ASND · NASDAQ · USD · US
This page tracks Ascendis Pharma A/s's ASND:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ASND:NASDAQ. ASND:NASDAQ is the stock-level entry point for investors researching Ascendis Pharma A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ascendis Pharma A/S is a publicly traded company listed under the ticker ASND, operating in the American market. The company has a market capitalization of approximately $15.83 billion. Ascendis Pharma focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- ASND:NASDAQ
- Asset type
- Stock
- Market cap
- $15.80B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Ascendis Pharma A/s ASND:NASDAQ stock context
This page tracks Ascendis Pharma A/s's ASND:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ASND:NASDAQ. ASND:NASDAQ is the stock-level entry point for investors researching Ascendis Pharma A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ascendis Pharma A/S is a publicly traded company listed under the ticker ASND, operating in the American market. The company has a market capitalization of approximately $15.83 billion. Ascendis Pharma focuses on developing innovative therapies to address unmet medical needs.
Latest news from Ascendis Pharma A/s
Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
August 25, 2026
Ascendis Pharma Reports Second Quarter 2026 Financial Results
August 13, 2026
Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivo...
June 30, 2026
Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
June 26, 2026
Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026
June 25, 2026
Ascendis Pharma A/s earnings calls
Ascendis Pharma A/S (ASND) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q4 2025 Earnings Call
February 11, 2026 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Ascendis Pharma A/s
Ascendis Pharma A/s investor report
Review AI stock analysis and investor report context for ASND:NASDAQ.
Ascendis Pharma A/s company profile
View the public company page for Ascendis Pharma A/s on 6ix.
Ascendis Pharma A/s news
Read company news and market updates connected to Ascendis Pharma A/s.
Ascendis Pharma A/s investor events
Find investor webinars, events, and replay context for Ascendis Pharma A/s.
Alternate listings
A14M6X:LSX
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
A710:GETTEX
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
A14M6X:LS
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
ASND:BOATS
US · USD
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
A1SN34:BMFBOVESPA
BR · BRL
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
DK0060606333:LS
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
ASNDN:BMV
MX · MXN
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
ASNDN:BIVA
MX · MXN
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
ASND1N:BMV
MX · MXN
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
A710:TRADEGATE
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
A42ANJ:LS
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.
ASND1N:BIVA
MX · MXN
Alternate listing for Ascendis Pharma A/s; the primary context on this page is ASND:NASDAQ.